Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Cash Flows From Operating Activities:
Net loss	$ (3,343,725)	$ (1,100,056)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	36,133	20,168
Accretion of debt discount	1,723,056	188,579
Stock-based compensation	0	59,000
Changes in assets and liabilities:
Prepaid expenses and other receivables	(550,211)	152,438
Inventory	(31,583)	(54,085)
Accounts payable	(145,898)	(103,135)
Liability due to related parties	(256,583)	(284,453)
Other liabilities and accrued expenses	363,052	43,950
Deferred revenue	515,731	0
Net cash used in operating activities	(1,690,028)	(1,077,594)
Cash Flows from Investing Activities:
Capitalized patent costs	(22,714)	(10,283)
Capitalized software development costs	(293,285)	0
Purchase of property and equipment	(82,222)	(1,999)
Net cash used in investing activities	(398,221)	(12,282)
Cash Flows from Financing Activities:
Costs incurred in relation to equity financing	0	(61,424)
Commission paid on note payable	0	(325,000)
Proceeds from issuance of notes	0	4,943,074
Proceeds from issuance of common stock in relation to equity financing	0	2,047,462
Proceeds from warrant exercise	2,963,658	394,475
Repayments of note payable	(1,500,000)	0
Repayment of insurance financing	0	(40,936)
Net cash provided by financing activities	1,463,658	6,957,651
Net (decrease) increase in cash	(624,591)	5,867,775
Effect of exchange rate changes on cash	18,973	(20,948)
Cash at beginning of period	31,865,371	106,107
Cash at end of period	31,259,753	5,952,934
Supplemental disclosure of non-cash financing activities:
Prepayment of equity compensation	25,000	0
Increase in stock subscriptions receivable	$ 0	$ 1,988,132